Frank Azzopardi

Davis Polk is advising Bio-Reference Laboratories, Inc. in connection with its approximately $1.47 billion acquisition by OPKO Health, Inc. Under the terms of the agreement, holders of Bio…

Davis Polk advised the initial purchasers in connection with a Rule 144A offering by Interactive Intelligence Group, Inc. of an aggregate principal amount of $150 million of its 1.25%…

Davis Polk is advising Micrel, Incorporated in connection with its sale to Microchip Technology Incorporated for a total equity value of approximately $839 million. The transaction,…

Davis Polk advised the initial purchasers in connection with a Rule 144A offering by CalAmp Corp. of $150 million aggregate principal amount of its 1.625% convertible senior notes due 2020…

Davis Polk is advising a GO Scale Capital-led consortium on its acquisition of an 80.1% interest in Philips’ combined LED components and Automotive lighting business. The transaction values…

Davis Polk advised PCH International Holdings in connection with its acquisition of certain assets associated with the Fab.com business (“Fab”), for an undisclosed amount of cash and equity…

Davis Polk is advising Temenos Group AG in connection with its acquisition of IGEFI Group s.à.r.l. (trading as Multifonds), a Summit Partners portfolio company. The consideration for the…

Davis Polk advised the joint book-running managers and representatives of the underwriters on a public offering by Laboratory Corporation of America Holdings (LabCorp) of $500 million…